Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Nitric Oxide vs Inhaled Epoprostenol in Pulmonary Hypertension
NCT04231084Phase 4Completed
- Sponsor
- Brigham and Women's Hospital
- Start
- Jan 2021
- Primary completion
- Aug 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of epoprostenol in pulmonary hypertension (PH), sponsored by Brigham and Women's Hospital. Started Jan 2021; status: completed.
02
Drugs
epoprostenol
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT04231084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04231084.